Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer and Johnson and Johnson back PhRMA code

Pfizer and Johnson and Johnson back PhRMA code

11th July 2008

Along with a number of other companies, Pfizer and Johnson & Johnson have expressed their support for the recently updated industry code of practice issued by Pharmaceuticals Research and Manufacturers of America (PhRMA).

The code covers the interaction between pharmaceutical companies and healthcare professionals, with the new update looking to offer improved guidance on issues such as grants and consultant arrangements, clinical practice guidelines and the provision of meals and entertainment.

Johnson & Johnson said its acceptance of the revised code is consistent with its continued dedication to guarantee the integrity of its relationship between doctors and its representatives and protect medical treatment and judgement from influences deemed to be inappropriate.

Pfizer said its support for the code underlines its dedication to work together with its customers in a transparent and responsible fashion.

“The revised code will supplement and enhance measures adopted by Johnson & Johnson and its pharmaceutical operating companies in 2002 when the first PhRMA Code was introduced,” the company said.

It added that its pharmaceutical subsidiaries would implement the new guidance by January 2009.

Johnson & Johnson notes that its own guidelines for responsible interactions with healthcare professionals is based on legal, regulatory and professional requirements that depend on the countries where it operates, in addition to industry codes of conduct.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.